The use of IVUS imaging can guide operators in a variety of clinical scenarios involving lower-extremity arterial and venous peripheral interventions, according to a new international consensus ...

It is feasible to forgo femoral access and go through the radial artery for many complex lower-extremity interventions, findings from the prospective R2P registry suggest. Across a range of PAD ...

In patients with peripheral artery disease, radial artery access is safe and feasible for peripheral vascular intervention. Radial artery access is safe and feasible for peripheral vascular ...

Please provide your email address to receive an email when new articles are posted on . Endovascular treatment via radial access for the treatment of peripheral artery disease was successful in 93.3% ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Independent analysis includes Centers for Medicare & Medicaid Services (CMS) data from over 700,000 peripheral arterial and peripheral venous intervention patients Data demonstrate a 32% reduction in ...

A new study published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) explores the safety and efficacy of using radial access (RA) for peripheral artery ...

DelveInsight's Peripheral Vascular Devices Market Insights report provides the current and forecast market analysis, individual leading peripheral vascular devices companies' market shares, challenges ...

The US Food and Drug Administration (FDA) has determined that paclitaxel-delivering stents and balloons for peripheral-artery interventions do not pose an excess mortality risk, the agency said today ...

Peripheral Interventions Market report provides an in-depth analysis of the current market landscape. It covers market size, segmentation, and major trends that are driving growth in the industry. Our ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...